Paper28001084
Resveratrol as an anti-cancer agent: A review.
Rauf A and 5 others. Crit Rev Food Sci Nutr, 2018. Cited by 496 papers, by iCite.
Cite this record
ConductScience Library. Resveratrol as an anti-cancer agent: A review. Papers, record 28001084. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28001084
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Stilbenes | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Antineoplastic Agents, Phytogenic | |
| Antioxidants | |
| Cell Line, Tumor | |
| Disease Models, Animal | |
| Fruit | |
| Humans | |
| Phytochemicals | |
| Resveratrol | |
| Sesquiterpenes | |
| Vitis | |
| Phytoalexins |
Source PubMed
Cited by322
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 496 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42892944 | Resveratrol Pretreatment and Decabromodiphenyl Ethane-Associated Hepatorenal Changes in a High-Dose Female Mouse Model: Redox Changes and Ferroptosis-Associated Markers. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42892944 | PubMed |
| 42857493 | Natural metabolites targeting macrophage polarization for non-small cell lung cancer therapy: a review of mechanisms and applications based on chemical classification. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42857493 | PubMed |
| 42797054 | REV-ERB-Mediated Regulation of Neural Functional Mechanisms by Phytochemicals in the Circadian System. | Nutrients | 2026 | https://conductscience.org/library/papers/42797054 | PubMed |
| 42670540 | Mechanisms and the Role of p38 MAPK Signaling in Doxorubicin-Induced Cardiotoxicity: A Review. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/42670540 | PubMed |
| 42577300 | Dietary resveratrol on growth performance, serum biochemical parameters, antioxidant capacity, and meat quality in broilers. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42577300 | PubMed |
| 42534730 | Polyphenols and microglial dynamics in neurodegenerative diseases: mechanistic advances and therapeutic perspectives. | PeerJ | 2026 | https://conductscience.org/library/papers/42534730 | PubMed |
| 42529906 | The Therapeutic Use of Natural Products in Myopia Prevention: Recent Applications. | Mol Nutr Food Res | 2026 | https://conductscience.org/library/papers/42529906 | PubMed |
| 42466361 | Luteolin-Treated 4T1 Cell-Derived Exosomes as Novel Antiproliferative Agents In Vitro and In Vivo. | Avicenna J Med Biotechnol | 2026 | https://conductscience.org/library/papers/42466361 | PubMed |
| 42391634 | Resveratrol in Combination Therapy: Mechanisms and Limitations of Resveratrol in Cancer, Regeneration, and Chronic Disease | Iran Biomed J | 2026 | https://conductscience.org/library/papers/42391634 | PubMed |
| 42358819 | Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational Opportunities. | Oncol Res | 2026 | https://conductscience.org/library/papers/42358819 | PubMed |
| 42357057 | Infill Pattern-Dependent Mechanical Properties and In Vitro Release Behavior of FDM 3D-Printed Resveratrol Amorphous Solid Dispersion Matrix Tablets. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/42357057 | PubMed |
| 42317278 | Developing bioactive-rich hybrid beverages: A metabolomic study of grape must co-fermentation with orange and apple juices. | Food Chem X | 2026 | https://conductscience.org/library/papers/42317278 | PubMed |
| 42256526 | SIRT1: Protean roles at the nexus of health, disease, and therapeutics. | J Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42256526 | PubMed |
| 42246193 | Plant‑derived natural products alleviate dexamethasone‑induced skeletal muscle atrophy by modulating FoxO (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42246193 | PubMed |
| 42121919 | The Role of TRAF6 in Cancer: From Molecular Mechanisms to Therapeutic Strategies. | Cells | 2026 | https://conductscience.org/library/papers/42121919 | PubMed |
| 42053794 | Resveratrol-mediated disruption of the CD73-adenosine-A2AR/A2BR axis induces antitumor activity in colon cancer cells. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42053794 | PubMed |
| 41971426 | The mechanism of the PI3K-AKT-mTOR signaling pathway in renal cell carcinoma: current developments and future prospects. | Front Oncol | 2026 | https://conductscience.org/library/papers/41971426 | PubMed |
| 41898364 | Combined Antineoplastic Effects of Metformin, Boric Acid and Resveratrol in SKOV3 Ovarian Cancer Cells. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898364 | PubMed |
| 41897471 | Reshaping Antioxidant Activity via Photoisomerization: A Comparative Theoretical Study of Pterostilbene and Resveratrol. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41897471 | PubMed |
| 41879695 | Polyphenols as Epigenetic Modulators of Health: A Holistic Approach to the Therapy and Prevention of Chronic Diseases. | Tunis Med | 2025 | https://conductscience.org/library/papers/41879695 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28001084
GET https://conductscience.org/api/papers/v1/28001084/cited_by?page=2